IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in...

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group

M. Feuring-Buske, M. Kneba, M. Unterhalt, A. Engert, M. Gramatzki, E. Hiller, L. Trümper, W. Brugger, H. Ostermann, J. Atzpodien, M. Hallek, E. Aulitzky, W. Hiddemann
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
79
Language:
english
Pages:
8
DOI:
10.1007/s002770000163
Date:
September, 2000
File:
PDF, 90 KB
english, 2000
Conversion to is in progress
Conversion to is failed